Tesla's board is pushing for Elon Musk's historic $56 billion compensation package, a deal that could potentially propel the CEO to become the first trillionaire in history as the company's valuation continues to soar.
Tesla investors have overwhelmingly approved Elon Musk's massive pay package, valued at approximately US$87.8 billion, in a landmark shareholder vote that could reshape the company's future leadership.
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
A New Brunswick hospital must compensate a patient $5,000 after staff failed to provide services in French, highlighting ongoing official language rights enforcement in Canada's only bilingual province.
An OCDSB education supervisor's compensation package has surged to nearly $350,000, raising questions about public sector spending and transparency in Ontario's school system.
Tesla shareholders have overwhelmingly approved Elon Musk's record-breaking compensation package while also greenlighting the company's move to Texas in a decisive victory for the controversial CEO.
Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Quebec physicians are taking legal action against Bill 15's salary provisions, claiming the government is violating constitutional rights and undermining fair compensation negotiations.
A groundbreaking $7.3 million settlement brings closure to Windsor high-rise residents displaced by a devastating fire, approved by a judge despite municipal objections. Discover how this decision impacts tenant rights and housing security in Ontario.
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Saskatchewan is preparing to introduce groundbreaking legislation ensuring fair market value compensation for firearms affected by the federal buyback program. Learn how this provincial move could set a national precedent.
Tesla shareholders face a monumental decision on Elon Musk's unprecedented $56 billion compensation package that could create the world's first trillionaire or trigger his departure from the electric vehicle giant.
Alberta's frontline heroes are fighting a hidden battle as PTSD claims face systemic delays and denials, leaving families in crisis and advocates demanding urgent reform.
The Quebec government is reopening negotiations with physicians over controversial payment reforms, aiming to transform how doctors are compensated while addressing healthcare system challenges.
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
World's largest sovereign wealth fund joins growing opposition to Musk's controversial compensation deal ahead of Tesla shareholder vote.
Boeing confronts its first civil trial as families of Ethiopian Airlines Flight 302 victims pursue damages. The landmark case could expose internal safety failures and set legal precedents for aviation accountability.
Exclusive look at why Canada's wildland firefighters are fighting for recognition as first responders and what changes would mean for their safety and compensation.
The Liberal government has rejected a significant pay raise recommendation for federally appointed judges, citing economic concerns and setting up potential tension with the judiciary.
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
A Vancouver Island resident learned an expensive lesson about travel insurance after a missed flight cost him thousands in a BC Civil Resolution Tribunal case.
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
Quebec medical specialists have secured a Superior Court hearing to challenge government-imposed fee reductions, setting up a major healthcare funding battle.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.